Ludwig University of Oxford's Olivia Lombardi presented a poster at #AACR24 titled 'Transcriptional programs underpinning reoccurring cancer cell states, plasticity and tumour phylogenies in clear cell kidney cancer' in a session focused on Tumor Evolution at Single Cell Resolution.

Abram Bunya Kamiza (Abram Kamiza), an AACR scholar-in-training award recipient from Johannesburg, South Africa, whose travel to #AACR24 was supported by the Ludwig Institute, discussed his trans-ethnic analysis of newly identified genomic regions linked to cervical cancer.

Ludwig Harvard Medical School's Stephanie Dougan spoke at #AACR24 about her lab's preclinical studies showing how drugs known as CDK4/6 inhibitors might be used in combination with checkpoint blockade immunotherapy to augment anti-tumor immunity without causing serious adverse reactions.

Ludwig Johns Hopkins Kimmel Cancer Center's Nickolas Papadopoulos, incoming co-editor-in-chief of Cancer Prevention Research, met with attendees at #AACR24 for an informal meet, greet and chat about the journal and the kinds of papers he and his colleague hope to publish.

Ludwig University of Oxford's Hannah Fuchs presented at #AACR24 her studies on the immunology of responses esophageal cancer patients enrolled in a clinical trial had to a combination of chemotherapy, anti-PD-L-1 checkpoint blockade immunotherapy and surgery.

Ludwig Weill Cornell Medicine's Anaïs Assouvie at #AACR24 discussing the work she presented there in a poster titled: 'Optimizing breast cancer therapy by modulating oxygen consumption.'

Ludwig Weill Cornell Medicine's Daniel Hirschhorn presented at #AACR24 his exploration of the biology underlying the relationship between positive responses to an immunotherapy regimen, incidence of adverse events in skin and the cutaneous activation of immune cells known as neutrophils.

The seven Ludwig-supported #AACR24 Scholars-in-Training with Ludwig Institute Deputy Scientific Director Pat Morin after a reception honoring winners of this year’s awards. For more: bit.ly/43Q7viL

In his Margaret Foti Award lecture at #AACR24 , Ludwig Institute Scientific Director Chi Van Dang told the story of his career unraveling the role of oncogenic MYC in cancer cell metabolism, growth & circadian biology & his efforts to translate his findings into new therapies.

Ludwig Weill Cornell Medicine's Jamie Brett at #AACR24 , discussing her exploration of the metabolic vulnerabilities of dedifferentiated liposarcoma.

Ludwig Weill Cornell Medicine's Mariam Mathew George Mariam Mathew George presented her research at #AACR24 in a poster titled 'Modeling tumor immunoediting under immune selective pressure to inform neoantigen landscape dynamics for effective cancer vaccines.'

Ludwig Weill Cornell Medicine's Sadna Budhu presented at #AACR24 her preclinical study examining the use of two distinct metabolic drugs to enhance anti-PD-1 immunotherapy.

Ludwig Weill Cornell Medicine's Vincent Panneton discusses his work at #AACR24 on an approach to harnessing the gut microbiome for cancer immunotherapy.

Ludwig University of Oxford’s Richard White richard white presented at #AACR24 his lab’s discoveries on how biophysical forces, especially compression, influence the distinct characteristics and behavior of cancer cells at the invasive edge of melanoma tumors.

Another #AACR24 scholar-in-training, Mohamed Gaber, attending the annual meeting with support of a Ludwig-funded travel award, presented his work in a poster session on the role of diet, nutrition and the microbiome across the cancer continuum.

Ludwig Harvard Medical School's Hideko Isozaki presented a poster @ #AACR24 titled, 'APOBEC3A drives tumor evolution through activation of ERVs in non-small cell lung cancer.' Her findings enrich our understanding of how this common cancer's develops resistance to a key targeted therapy.

Ludwig University of Oxford’s Samvid Kurlekar & Joanna C Lima presented @ #AACR24 a study showing HIF1A & 2A, which govern responses to hypoxia, contribute differently to cellular adaptations to loss of the tumor suppressor Vhl in the kidney, an event that drives a type of renal cancer.

Ludwig Harvard Medical School's Liron Bar-Peled presented at #AACR24 his lab’s development and application of “An ‘omics approach to drug discovery.”

Ludwig Harvard Medical School Co-director george demetri, a scientist and physician famed for his contributions to cancer drug development, shared his unique perspective in opening remarks for a session at #AACR24 titled: 'In the Eye of the Beholder: Equipoise in Cancer Clinical Trials.'

Ludwig Stanford University's Crystal Mackall gave a plenary talk at #AACR24 on strategies to design CAR-T cells to overcome the multiple impediments that limit their ability to kill cancer cells in solid tumors.